Recent technological advances have made it possible to collect multiple types of genomics data on the same set of patients. It is of great interest to integrate multiple genomics data types together for predicting disease outcomes. We propose a variable selection method, termed Integrative Boosting (I-Boost), that makes proper use of all available clinical and genomics data in predicting individual patient survival time. Through simulation studies and applications to data sets from
methylation, and expression of ∼200 proteins/phosphoproteins. The availability of multiple data types has enabled researchers to address a variety of important questions.
For example, patients can be more precisely classified into molecular subtypes based on integrative clustering of multiple genomics data types or platforms [6, 7, 8] . In addition, it is possible to identify genes that are related to patient survival time by decomposing the expression of each gene into a component that is explained by the methylation level and a component that is not [9] .
One unsolved issue in cancer genomics is the prognostic value of integrated genomics and clinical data versus clinical data only. Yuan et al. [10] compared models with clinical data only versus models with both clinical and genomics data on various cancer types and concluded that genomics data provide only a limited gain in survival prediction accuracy. In their analysis, however, potential differences among data types were not taken into account. For breast cancer, for instance, the combination of genomics and clinical data has been shown to improve outcome predictions [11, 12] . A major goal of the present work is to fully explore the predictive power of integrating clinical and genomics data together.
A second unsolved issue is the prognostic value of individual gene expression values (∼25,000) versus a predefined set of gene expression signatures or "modules" (∼500).
To overcome the limitations of LASSO, elastic net, and existing boosting methods, we develop a novel method, termed Integrative Boosting (I-Boost), which combines elastic net with boosting. In I-Boost, the prediction rule is constructed iteratively, where at each iteration, the predictive power of each data type (conditional on the current prediction rule) is evaluated separately and the most predictive data type is selected to update the prediction rule using elastic net. Thus, independent signal from each data type can be incorporated into the prediction rule, and small but predictive data types will not be dominated by data types with large numbers of variables. In addition, the penalties on the regression parameters are learned data-adaptively and separately for different data types. Herein, we demonstrate the advantages of I-Boost using simulation studies and empirical data from the TCGA on patients with eight different cancer types. More importantly, we use I-Boost to address the aforementioned three unsolved issues in cancer genomics.
Results and discussion

Background
Suppose that there are K types of clinical or genomics predictors, with d k components for the kth type (k = 1, . . . , K). For k = 1, . . . , K, let X (k) denote the d k -vector of predictors of the kth type. Write X = (X (1)T , . . . , X (K)T ) T . Let T denote the survival time of interest. We relate T to X through the proportional hazards model [23] , such that the conditional hazard function of T given X takes the form of h 0 (t) exp(β T X), where h 0 (t) is an arbitrary baseline hazard function, β = (β (1)T , . . . , β (K)T ) T , and β is a d k -vector of regression parameters associated with X (k) .
The survival time T is subject to right censoring by C, such that we observe Y ≡ min(T, C) and ∆ ≡ I(T ≤ C), where I(·) is the indicator function. For a study with n patients, the data consist of (Y i , ∆ i , X i ) (i = 1, . . . , n). The partial likelihood [24] for β 
LASSO and elastic net
Because X is high-dimensional, it is not feasible to estimate β by maximizing the partial likelihood. One possible remedy is to impose sparsity assumptions on β and adopt penalization methods, such as LASSO [13] and elastic net [14] . LASSO estimates β by maximizing the L 1 -penalized log-partial likelihood function log L(β) − λ LASSO and elastic net is described in Methods.
For both LASSO and elastic net, the penalty term dominates under large values of λ, and the parameter estimates tend to be small with some values being exactly zero.
Unlike LASSO, elastic net exhibits the grouping effect in that the regression parameters for a group of highly correlated variables tend to be equal, which is desirable in the context of gene selection [14] . Both LASSO and elastic net impose the same penalization on each regression parameter and thus do not distinguish different types of predictors.
As a result, these methods may be inefficient when certain data types are much more predictive than others.
I-Boost
To account for the differential predictive power of different data types, we propose a boosting algorithm called I-Boost. Boosting is an iterative optimization algorithm that minimizes a loss function {Y, f (X )} over a class of functions of predictors f (X ), where
. . , X n ), and (Y, f (X )} measures the deviation of the prediction f (X ) from the outcome Y. At each iteration, we update f (X ) additively by the value b(X ; β) up to a scaling factor, where b is a fixed basis function, and β is a vector of parameters. Specifically, at the mth iteration, we find β (m) that minimizes {Y, f m−1 (X )+b(X ; β (m) )}, possibly under some constraints on β (m) , where f m−1 is the estimate of f at the (m − 1)th iteration. Then, we set
for some fixed step-length factor v ∈ (0, 1]. We terminate the iterations when some stopping criterion is satisfied.
In I-Boost, we set the loss function {Y, f (X )} to be the negative log-partial likelihood function and the basis function to be b(X ;
is the vector of the kth type of predictors for the ith patient, and the data type k is selected separately at each iteration based on the values of the loss function obtained using different data types. To handle high-dimensional data, we impose an elastic-net penalty on β (m) in the optimization step. Effectively, we perform maximum penalized log-partial likelihood estimation with an offset term f m−1 (X ) using a single data type at each iteration. Unlike existing boosting methods, such as component-wise boosting, the basis function in our case is a function of all variables of a data type instead of a single variable. This choice of basis function is motivated by the expectations that some data types are much more predictive than others and that the inclusion of less predictive data types may reduce the prediction accuracy of the model. By considering each data type separately, we perform selection on the data-type level at each iteration.
We propose two versions of I-Boost, namely I-Boost-CV and I-Boost-Permutation, which use cross validation and permutation, respectively, to choose the tuning parameters of elastic net at each iteration. The permutation procedure randomly permutes the outcome variables in order to remove association between the predictors and the outcome, and the tuning parameters are chosen such that no predictor is selected in half of the permuted data sets. The procedures are described in detail in Methods.
Simulation studies
We conducted simulation studies to evaluate the performance of LASSO, elastic net, and the two versions of I-Boost. We considered three simulation settings, with different distributions of signals across the data types. In all three settings, a relatively large
proportion of the signals is contributed by the clinical variables. The distributions of signals are shown in Figure 1 , and the details of the simulation settings are provided in
Methods.
We assessed the performance of the methods by the quality of prediction and parameter estimation. For prediction, we report the correlation between the estimated risk
and the true risk score
and β always selects the largest number of variables, followed by elastic net, LASSO, and IBoost-Permutation. In particular, I-Boost-CV tends to select a relatively large number of variables from data types with very weak or no signal. Nevertheless, evaluation of the mean-squared error reflects that the magnitude of the estimated regression parameters for those data types is small. In fact, both versions of I-Boost yield more accurate estimation than LASSO and elastic net in all cases.
For prediction, the two I-Boost methods perform the best overall. In all settings, IBoost-CV produces more accurate prediction than all other methods. In Settings 1 and 2, where most signals are concentrated on only one or two data types, I-Boost-Permutation produces more accurate prediction than both elastic net and LASSO. In Setting 3, IBoost-Permutation performs similarly to elastic net, while LASSO performs worse than I-Boost-Permutation. Between the two versions of I-Boost, I-Boost-CV tends to yield better prediction than I-Boost-Permutation, possibly because of the larger number of variables selected by I-Boost-CV. Thus, if the main interest is the selection of relevant variables, then one might consider I-Boost-Permutation for more conservative variable selection, even though this method is somewhat inferior in prediction when compared to I-Boost-CV.
We implemented LASSO, elastic net, and the two versions of I-Boost using R-3.2.2 on a 2.93 GHz Xeon Linux computer. On average, performing LASSO, elastic net, I-Boost-Permutation, and I-Boost-CV on one simulated data set (that consists of 500 subjects, 6 data types, and 1,294 predictors) takes about 2 minutes, 14 minutes, 3 hours, and 38 hours, respectively. I-Boost-CV is computationally intensive because in each iteration, cross validation is conducted on a three-dimensional grid. By contrast, in each I-Boost-Permutation iteration, the tuning parameter α is fixed at 1, no cross validation is involved in the selection of λ, and LASSO is performed only once for each data type.
Therefore, I-Boost-Permutation may serve as a computationally efficient alternative to I-Boost-CV.
Evaluation of LASSO, elastic net, and I-Boost using TCGA data
We next evaluated the performance of the methods using three TCGA data sets, namely the lung adenocarcinoma (LUAD) data set, the kidney renal clear cell cancer (KIRC) data set, and a pan-cancer data set derived from ∼1,400 patients that represents eight different tumor types considered by Hoadley et al. [25] ; see Methods for a detailed description of the data sets and the evaluation procedure. For each data set, we first split the data 30 times into training and testing sets. We then performed LASSO, elastic net, and the two versions of I-Boost for various combinations of data types on patients from the training set of each split. For each combination of data types and each split, we calculated the risk scores for patients in the testing set using the estimates from the corresponding training set, and we used the concordance index (C-index) [26] to evaluate the prediction accuracy of the risk scores.
The average C-index values over the splits obtained from LASSO and elastic net are given in Figure 2 . For the KIRC and pan-cancer data sets, the prediction tends to be much better than random (i.e., the C-index values are much larger than 0.5). For the LUAD data set, which has a small sample size, some of the models yield relatively poor prediction (with C-index values smaller than 0.6). For many models, the predictive performance of elastic net is either similar or superior to LASSO.
For LASSO and elastic net, the models containing more data types as predictors do not necessarily perform better than those with fewer data types. One possible explanation is that the extra data types may contain very little relevant information on patient survival, such that adding those data types introduces more noise than signal into the model. In practice, however, it is challenging to decide which data types to consider without prior knowledge of their importance. is particularly large when the sample size is small and the number of predictors is large.
The difference is likely due to the fact that I-Boost involves the selection of data types, so that the large and non-predictive data types would not be selected in most iterations, and their presence would not substantially worsen the prediction accuracy. For the KIRC and pan-cancer data sets, I-Boost-CV yields better prediction than I-Boost-Permutation, whereas for LUAD, there are no clear differences between the two methods.
Prognostic value of integrated clinical and genomics data
To When the same comparisons are made using LASSO or elastic net, however, the inclusion of genomic variables in the models does not appreciably improve prediction.
Evaluation of gene expression modules
To 
Comparison among genomics data types
To evaluate the relative prognostic value of each genomics data type, we formed a series of nested models as follows. We began with the model containing clinical variables only. Then, we compared the models containing clinical variables and a type of genomic variables and selected the most predictive model. This process was repeated until all data types were included, and the model selected at each step contained all of the previously selected data types. Individual gene expression data were not considered in this analysis.
The order in which the genomics data types entered the models reflects their relative importance. We performed this procedure for elastic net and the two versions of IBoost. For the LUAD, KIRC, and pan-cancer data sets, the C-index values for the series of models are plotted in Figure 6 , and the data type selected at each step is shown. We also plotted the average number of variables selected for each model. 
Important predictors for the LUAD, KIRC, and pan-cancer data sets
To obtain the final models of important predictors, we performed I-Boost-Permutation on the LUAD, KIRC, and pan-cancer data sets. The final models are shown in Tables   1-3 for the LUAD, KIRC, and pan-cancer data sets, respectively.
Age and pathological nodal status are negatively associated with survival time in the LUAD, KIRC, and pan-cancer data sets. Age has been reported to be prognostic for many cancer types [27, 28, 29] . In the analysis of the pan-cancer data set, cancer types were selected, which is logical, since the survival time is known to depend on cancer types [25] . 
Conclusions
In this paper, we present a novel method, termed I-Boost, for variable selection and outcome prediction that is especially powerful when one wishes to simultaneously consider multiple genomics and/or proteomics data types. We used simulation studies and real data to demonstrate that in the presence of multiple data types with diverse signal strength, I-Boost produces better outcome prediction than LASSO and elastic net.
We proposed two versions of I-Boost, namely I-Boost-CV and I-Boost-Permutation. I-Boost-CV yields more accurate prediction than I-Boost-Permutation, but it generally selects many more variables and is computationally more intensive. By contrast, IBoost-Permutation is computationally efficient and selects much fewer variables, which may be preferable for follow-up experiments.
Consistent with the current literature, we found that clinical variables are strong predictors of survival time. With I-Boost, we were able to build upon the clinical variables and extract additional useful information from genomic variables in order to improve the prediction; the improvement that we obtained with I-Boost was considerably larger than that obtained by either LASSO or elastic net. We also compared the use of individual gene expression data versus gene modules and found that the use of gene modules leads to improvement in prediction accuracy and more interpretable results. When we considered the selected I-Boost models, clinical variables (e.g., age, tumor size, and pathological nodal status) were strong predictors of survival. The I-Boost methods also selected several gene modules that were previously identified as prognostic of outcomes, whether positive or negative.
Our study has limitations. The main limitation is that the LUAD and KIRC data sets pertain to a relatively small number of patients, with an even smaller number of observed events. This limitation motivated us to combine eight solid epithelial tumor types to form a large pan-cancer data set. The analyses on the pan-cancer data might not properly account for heterogeneity across different cancer types. Another limitation of our study is that the quality of the clinical data varies across different cancer types;
for example, the follow-up time for some cancer types was quite short.
In summary, we demonstrated that the performance of I-Boost is superior to that of elastic net and LASSO and that the performance of gene modules is superior to that of the totality of individual genes. The I-Boost methodology is applicable to any disease states where multiple types of genomics and/or proteomics data are available and thus has potential applications beyond cancer studies.
Methods
Data description After removing patients with missing data, the total sample size was 1,420, including 202 LUAD patients and 195 KIRC patients. All survival times were censored at five years if the patients were still in the study at that time point. For the pan-cancer data set, the median follow-up time was 16.8 months, and the censoring rate was 77.6%. For the subset of LUAD patients, the median follow-up time was 13.9 months, and the censoring rate was 71.3%. For the subset of KIRC patients, the median follow-up time was 28.9 months, and the censoring rate was 63.6%.
LASSO and elastic net
We implemented LASSO and elastic net using the R-package "glmnet" [38] and used fivefold cross validation to select the tuning parameters. For elastic net, cross validation was performed over a two-dimensional grid of (α, λ), while for LASSO, α was set to be 1.
For elastic net, the grid for α was chosen to be (0.05, 0.1, 0.2, . . . , 1.0), and a grid for λ was chosen separately for each α using the default settings of glmnet. (A minimum value of 0.05 was considered for α, because α too close to 0 may result in too many variables being selected; in particular, no sparsity is imposed if α = 0.) To make the selection procedure more stable, we repeated the split and evaluation procedure five times, and the cross-validation errors were averaged over the five repetitions.
I-Boost
The I-Boost algorithm is given as follows:
1. Set f 0,i = 0 for i = 1, . . . , n, and let
2. Consider m = 1, 2, . . .:
(a) For a given k m ∈ {1, . . . , K}, calculate
using the coordinate-descent algorithm [38] , where
is the partial likelihood with offset term f and covariates X (k) , α m and λ m are tuning parameters, f = (f 1 , . . . , f n ) T , and
is the elastic net penalty. The selection of k m , α m , and λ m is described below. Empirical studies suggested that a small value of the step-length factor v often improves and almost never worsens the performance of boosting [40] . Therefore, it is recommended that v is chosen to be as small as possible while the algorithm remains computationally feasible. In the settings we have considered, the performance of I-Boost is not sensitive to v within the range of v ∈ (0.05, 0.5). Therefore, we set v to a moderately small value of 0.1.
Conventional boosting methods require a stopping criterion to avoid over-fitting.
In our experience, however, because the tuning parameters are selected separately at each iteration for I-Boost, they eventually lead to shrinkage of all (current) parameter estimates. Therefore, we do not adopt a separate procedure to determine the stopping time of the iteration. We terminate the iteration when f m remains constant for five consecutive iterations.
Simulation studies
In the simulation studies, we considered all data types except individual gene expression data. For each simulation data set, we generated the predictors by sampling without replacement whole vectors of predictors from the TCGA pan-cancer data set. We generated the survival time from a proportional hazards model with the baseline hazard function h 0 (t) = t and generated the censoring time from an exponential distribution with a mean chosen to result in censoring proportion of about 50%. We set the sample size n to 500 in all settings.
The regression parameters were chosen to produce a different proportion of signals across data types, where the signal of data type k is defined to be Var(X (k)T β Because we considered a total of six data types, I-Boost-CV is computationally demanding. To lessen the computational burden, we set v = 0.2 instead of the value 0.1 used in real data analysis.
Assessment of Prediction
To assess an analysis method, we split the data into 30 training and testing sets with a 3:2 ratio of sample sizes. We used the R-package "sampling" To quantify the prediction accuracy, we used the C-index. Let T i be the survival time and X i be a vector of predictors for the ith subject, and let β be a vector of regression parameters. The risk score is defined as X Tables   Table 1: Analysis results from I-Boost-Permutation for the TCGA LUAD data set. 
